危重型COVID-19患者呼吸衰竭肺病理生理中炎症细胞因子的关联
COVID-19组中58%发生ARDS、62%需机械通气、12%接受ECMO、23%死亡。仅在COVID-19组发现IL-6与PaO2/FiO2(rho -0.531,p=0.0052)及静态肺顺应性(rho -0.579,p=0.033)呈负相关;ARDS诊断当日血清IL-6和IL-1β显著升高。IL-1β或TNF-α未见类似观察。
要点
- 仅在COVID-19组发现IL-6与PaO2/FiO2负相关(rho -0.531,p=0.0052),对照组无此关联。
- 仅在COVID-19组发现IL-6与静态肺顺应性负相关(rho -0.579,p=0.033)。
- ARDS诊断当日血清IL-6和IL-1β显著升高,提示与ARDS发生相关。
- IL-1β或TNF-α未观察到与肺功能指标的类似关联。
- COVID-19组58%发生ARDS、62%需机械通气、12%接受ECMO、23%死亡。
适用人群与场景
- 场景为ICU,病情阶段为危重型COVID-19呼吸衰竭。
诊断标准与关键阈值
- 原文未提及诊断标准的具体名称或评分界值。
- 肺功能结局指标为PaO2/FiO2比值和静态肺顺应性。
- ARDS诊断依据原文未具体说明。
处置流程与药物剂量
- 干预为每日测量血清IL-1β、IL-6、IL-10、TNF-α。
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 干预:每日测量血清IL-1β、IL-6、IL-10、TNF-α;对照:非COVID-19危重型呼吸衰竭ICU对照组。
- 主要终点:COVID-19组IL-6与PaO2/FiO2负相关(rho -0.531,p=0.0052),与静态肺顺应性负相关(rho -0.579,p=0.033);对照组无此关联。
- ARDS诊断当日血清IL-6和IL-1β显著升高。
- COVID-19组58%发生ARDS、62%需机械通气、12%接受ECMO、23%死亡。
- IL-1β或TNF-α未观察到与PaO2/FiO2或静态肺顺应性的类似关联。
证据类型、等级与局限
- 证据类型:多中心前瞻性观察性研究。
- 原文未述局限性。
对床旁实践的改变
- 原文提示在危重型COVID-19呼吸衰竭患者中,血清IL-6与PaO2/FiO2及静态肺顺应性的负相关为SARS-CoV-2感染所特有,可能有助于理解COVID-19呼吸衰竭的病理生理。
- 原文未提及基于此改变具体临床处置的建议;适用与不适用人群、常见陷阱原文未提及。
指南或共识出处
- 原文未提及
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: The majority of coronavirus disease 2019 mortality and morbidity is attributable to respiratory failure from severe acute respiratory syndrome coronavirus 2 infection. The pathogenesis underpinning coronavirus disease 2019-induced respiratory failure may be attributable to a dysregulated host immune response. Our objective was to investigate the pathophysiological relationship between proinflammatory cytokines and respiratory failure in severe coronavirus disease 2019.
DESIGN: Multicenter prospective observational study.
PATIENTS: Critically ill patients with coronavirus disease 2019 and noncoronavirus disease 2019 critically ill patients with respiratory failure (ICU control group).
INTERVENTIONS: Daily measurement of serum inflammatory cytokines.
MEASUREMENTS AND MAIN RESULTS: Demographics, comorbidities, clinical, physiologic, and laboratory data were collected daily. Daily serum samples were drawn for measurements of interleukin-1β, interleukin-6, interleukin-10, and tumor necrosis factor-α. Pulmonary outcomes were the ratio of Pao2/Fio2 and static lung compliance. Twenty-six patients with coronavirus disease 2019 and 22 ICU controls were enrolled. Of the patients with coronavirus disease 2019, 58% developed acute respiratory distress syndrome, 62% required mechanical ventilation, 12% underwent extracorporeal membrane oxygenation, and 23% died. A negative correlation between interleukin-6 and Pao2/Fio2 (rho, -0.531; p = 0.0052) and static lung compliance (rho, -0.579; p = 0.033) was found selectively in the coronavirus disease 2019 group. Diagnosis of acute respiratory distress syndrome was associated with significantly elevated serum interleukin-6 and interleukin-1β on the day of diagnosis.
CONCLUSIONS: The inverse relationship between serum interleukin-6 and Pao2/Fio2 and static lung compliance is specific to severe acute respiratory syndrome coronavirus 2 infection in critically ill patients with respiratory failure. Similar observations were not found with interleukin-β or tumor necrosis factor-α.
参考来源
- Stukas S, Hoiland RL, Cooper J, et al. The Association of Inflammatory Cytokines in the Pulmonary Pathophysiology of Respiratory Failure in Critically Ill Patients With Coronavirus Disease 2019. Crit Care Explor. 2020. PMID: 33063041. doi:10.1097/CCE.0000000000000203
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。